Sanket Shah, MD
Retina Specialist · Milpitas, CANPI 1528355799
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,436 of the $3,734 with a category attached, or 65.2%. 18 manufacturers reported payments, led by Novartis at 36.8% of the total. Reporting peaked in 2019 at $1,720 and has fallen 81.4% since, to $321 in 2025. That places this record below the midpoint for retina specialist clinicians in CA, where the typical reported total is $3,667.
Across 44 payments — averaging $84.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- PTC Therapeutics, Inc.$500
- Bausch & Lomb Americas Inc.$262
- Bausch & Lomb, A Division Of Bausch Health US, LLC$222
- Glaukos Corporation$209
- AbbVie$159
- plus $1K from 12 others
Across 3 payments — averaging $20,829 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$62K
What the payments were for
- Consulting fees$65017%
- Travel & lodging$64817%
- Food & beverage$2,43665%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEOVU$907
- TENEO$141
- iStent inject W$130
- Syfovre$129
- OZURDEX$125
- Rhopressa$125
- Rocklatan$125
- INVELTYS$124
- BUPARLISIB$122
- MIEBO$121
- XIIDRA$121
- enVista MX60 IOL$121
- Tecnis Simplicity$117
- Kahook Dual Blade$116
- Streamline Surgical System$116
- Ahmed Glaucoma Valve$116
- LOTEMAX$106
How this compares
$3,734 in reported general payments places this provider in the 50th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 51 | $2,426 |
| Latanoprost | 56 | $754 |
| Ketorolac Tromethamine | 20 | $671 |
| Brimonidine Tartrate | 44 | $582 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $526 |
| ErythromycinErythromycin Base | 30 | $396 |
| Ofloxacin | 13 | $197 |
| Timolol Maleate | 14 | $105 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Milpitas
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Roger GoldbergWalnut Creek$1.1M
- Baruch KuppermannIrvine$1M
- Carlos Medina MendezSacramento$548K
- Michael JavaheriBeverly Hills$540K
- Esther KimSanta Ana$367K
- Diana DoStanford$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.